The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.
Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...
The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...
Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.
It’s finally showtime for the 15th edition of YourStory’s flagship conference, TechSparks 2024! The festive season is here ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback